BioCentury | Jul 3, 2020
Management Tracks

Angus Grant joins BeiGene; plus changes at Sarepta, RegenxBio, BioMarin, Novavax, Whitehead, Akcea and more

...Inc. (NASDAQ:AMAG). Oncopeptides AB (SSE:ONCO) hired Marty Duvall as CEO. Duvall, who was CEO of Tocagen Inc....
BioCentury | Feb 21, 2020
Product Development

Feb. 20 Product Development Quick Takes: Priority Review puts BioMarin on track to score first hemophilia gene therapy approval in U.S.; plus Gilead-CDC, Genfit

...motor and phonic tics compared with placebo. Forte to trade on NASDAQ following reverse-merger with Tocagen...
...skin disease company Forte Biosciences Inc. plans to go public via a reverse merger with Tocagen Inc....
...bromide/fluticasone furoate/vilanterol, Fluticasone furoate/vilanterol/umeclidinium, fluticasone furoate/umeclidinium/vilanterol, FF/UMEC/VI (GSK2834425) BioMarin Pharmaceutical Inc. Gilead Sciences Inc. Genfit S.A. Teva Pharmaceutical Industries Ltd. Tocagen Inc. GlaxoSmithKline...
BioCentury | Sep 13, 2019
Clinical News

Sept. 12 Clinical Quick Takes: Celgene meets in Phase III for AML maintenance therapy; plus Roche, Tocagen, Adverum, Daiichi Sankyo, Apple, Navitor

...of patients with lower levels of PD-1/PD-L1. Tocagen's combo fails Phase III brain cancer study Tocagen Inc....
...of a retroviral replicating vector that delivers the CD gene, followed by an oral antifungal. Tocagen's...
...Other), Anti-PDL1 (Other) Vocimagene amiretrorepvec/extended release flucytosine (Toca 511/Toca FC) ADVM-022 (AAV.7m8-aflibercept) satralizumab (SA237, RG6168) NV-5138 Daiichi Sankyo Co. Ltd. Genentech Inc. Roche Tocagen Inc. Adverum...
BioCentury | Jun 29, 2019
Finance

All eyes on new modality launches, cancer and rare disease data in 3Q19

...and heavy menstrual bleeding associated with uterine fibroids Phase III data; submit NDA 3Q19; 4Q19 Tocagen Inc....
BioCentury | May 21, 2019
Clinical News

May 21 Clinical Quick Takes: Array gains on colorectal cancer plans; plus Tocagen, Promedior

...the data for marketing approval next half. Tocagen down on glioma immunotherapy update Shares of Tocagen Inc....
...Moy, Assistant Editor Mektovi binimetinib/Braftovi encorafenib/cetuximab PRM-151, rhPTX-2 Vocimagene amiretrorepvec/extended release flucytosine (Toca 511/Toca FC) Array BioPharma Inc. Novartis AG Promedior Inc. Tocagen Inc....
BioCentury | Apr 15, 2019
Company News

Management tracks: GW Pharmaceuticals, Aurinia

...Housley becomes CFO. Insys also promoted SVP R&D Venkat Goskonda to CSO. Gene therapy company Tocagen Inc....
...since Asha Das left the company in November, will return to the board of directors. Tocagen...
...will remain an adviser and board member. Mary Romeo, Staff Writer Aurinia Pharmaceuticals Inc. GW Pharmaceuticals plc Insys Therapeutics Inc. Tocagen Inc....
BioCentury | Apr 6, 2019
Finance

Big caps under pressure

...NYSE: MYOV) Relugolix Treat heavy menstrual bleeding associated with uterine fibroids Phase III data 2Q19 Tocagen Inc....
BioCentury | Jan 5, 2019
Finance

Ready to launch

...GmbH (NYSE:MYOV) Relugolix Uterine fibroids Phase III data (2 trials); submit NDA 2Q19; 3Q19; 4Q19 Tocagen Inc....
BioCentury | Nov 19, 2018
Company News

Management tracks: Brickell, Genevant

...effective Nov. 29. Tassé was CEO of Alcresta Therapeutics Inc. (Warren, N.J.). Gene therapy company Tocagen Inc....
...Das will leave the company Nov. 23 to focus on "unforeseen and immediate personal matters." Tocagen...
...a director, acting CMO. Kunkel was acting CMO at Loxo Oncology Inc. (NASDAQ:LOXO) from 2013-14. Tocagen...
BioCentury | Apr 20, 2018
Company News

ApolloBio licenses Tocagen's immunotherapy

...in Taiwan and China, including Hong Kong and Macau, to treat high grade glioma (HGG). Tocagen...
...delivers the cytosine deaminase (CD) gene, followed by Toca FC extended-release flucytosine, an oral antifungal. Tocagen Inc....
...Calif. ApolloBio Corp. (NEEQ:430187), Beijing, China Business: Cancer Sandi Wong Vocimagene amiretrorepvec/extended release flucytosine (Toca 511/Toca FC) ApolloBio Corp. Tocagen Inc....
Items per page:
1 - 10 of 39
BioCentury | Jul 3, 2020
Management Tracks

Angus Grant joins BeiGene; plus changes at Sarepta, RegenxBio, BioMarin, Novavax, Whitehead, Akcea and more

...Inc. (NASDAQ:AMAG). Oncopeptides AB (SSE:ONCO) hired Marty Duvall as CEO. Duvall, who was CEO of Tocagen Inc....
BioCentury | Feb 21, 2020
Product Development

Feb. 20 Product Development Quick Takes: Priority Review puts BioMarin on track to score first hemophilia gene therapy approval in U.S.; plus Gilead-CDC, Genfit

...motor and phonic tics compared with placebo. Forte to trade on NASDAQ following reverse-merger with Tocagen...
...skin disease company Forte Biosciences Inc. plans to go public via a reverse merger with Tocagen Inc....
...bromide/fluticasone furoate/vilanterol, Fluticasone furoate/vilanterol/umeclidinium, fluticasone furoate/umeclidinium/vilanterol, FF/UMEC/VI (GSK2834425) BioMarin Pharmaceutical Inc. Gilead Sciences Inc. Genfit S.A. Teva Pharmaceutical Industries Ltd. Tocagen Inc. GlaxoSmithKline...
BioCentury | Sep 13, 2019
Clinical News

Sept. 12 Clinical Quick Takes: Celgene meets in Phase III for AML maintenance therapy; plus Roche, Tocagen, Adverum, Daiichi Sankyo, Apple, Navitor

...of patients with lower levels of PD-1/PD-L1. Tocagen's combo fails Phase III brain cancer study Tocagen Inc....
...of a retroviral replicating vector that delivers the CD gene, followed by an oral antifungal. Tocagen's...
...Other), Anti-PDL1 (Other) Vocimagene amiretrorepvec/extended release flucytosine (Toca 511/Toca FC) ADVM-022 (AAV.7m8-aflibercept) satralizumab (SA237, RG6168) NV-5138 Daiichi Sankyo Co. Ltd. Genentech Inc. Roche Tocagen Inc. Adverum...
BioCentury | Jun 29, 2019
Finance

All eyes on new modality launches, cancer and rare disease data in 3Q19

...and heavy menstrual bleeding associated with uterine fibroids Phase III data; submit NDA 3Q19; 4Q19 Tocagen Inc....
BioCentury | May 21, 2019
Clinical News

May 21 Clinical Quick Takes: Array gains on colorectal cancer plans; plus Tocagen, Promedior

...the data for marketing approval next half. Tocagen down on glioma immunotherapy update Shares of Tocagen Inc....
...Moy, Assistant Editor Mektovi binimetinib/Braftovi encorafenib/cetuximab PRM-151, rhPTX-2 Vocimagene amiretrorepvec/extended release flucytosine (Toca 511/Toca FC) Array BioPharma Inc. Novartis AG Promedior Inc. Tocagen Inc....
BioCentury | Apr 15, 2019
Company News

Management tracks: GW Pharmaceuticals, Aurinia

...Housley becomes CFO. Insys also promoted SVP R&D Venkat Goskonda to CSO. Gene therapy company Tocagen Inc....
...since Asha Das left the company in November, will return to the board of directors. Tocagen...
...will remain an adviser and board member. Mary Romeo, Staff Writer Aurinia Pharmaceuticals Inc. GW Pharmaceuticals plc Insys Therapeutics Inc. Tocagen Inc....
BioCentury | Apr 6, 2019
Finance

Big caps under pressure

...NYSE: MYOV) Relugolix Treat heavy menstrual bleeding associated with uterine fibroids Phase III data 2Q19 Tocagen Inc....
BioCentury | Jan 5, 2019
Finance

Ready to launch

...GmbH (NYSE:MYOV) Relugolix Uterine fibroids Phase III data (2 trials); submit NDA 2Q19; 3Q19; 4Q19 Tocagen Inc....
BioCentury | Nov 19, 2018
Company News

Management tracks: Brickell, Genevant

...effective Nov. 29. Tassé was CEO of Alcresta Therapeutics Inc. (Warren, N.J.). Gene therapy company Tocagen Inc....
...Das will leave the company Nov. 23 to focus on "unforeseen and immediate personal matters." Tocagen...
...a director, acting CMO. Kunkel was acting CMO at Loxo Oncology Inc. (NASDAQ:LOXO) from 2013-14. Tocagen...
BioCentury | Apr 20, 2018
Company News

ApolloBio licenses Tocagen's immunotherapy

...in Taiwan and China, including Hong Kong and Macau, to treat high grade glioma (HGG). Tocagen...
...delivers the cytosine deaminase (CD) gene, followed by Toca FC extended-release flucytosine, an oral antifungal. Tocagen Inc....
...Calif. ApolloBio Corp. (NEEQ:430187), Beijing, China Business: Cancer Sandi Wong Vocimagene amiretrorepvec/extended release flucytosine (Toca 511/Toca FC) ApolloBio Corp. Tocagen Inc....
Items per page:
1 - 10 of 39